These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 5123613)
1. Proposals for the clinical assessment of 252 Cf in Manchester. Jackson AW Br J Radiol; 1971 Nov; 44(527):904. PubMed ID: 5123613 [No Abstract] [Full Text] [Related]
2. [252Cf brachytherapy]. Sugiyama T; Kaneta K Gan No Rinsho; 1983 May; 29(6):702-7. PubMed ID: 6876439 [TBL] [Abstract][Full Text] [Related]
5. Present status of the treatment of malignant neoplasms by 252Cf brachytherapy. Maruyama Y Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Mar; 44(3):483-93. PubMed ID: 6462896 [No Abstract] [Full Text] [Related]
6. [Intracavitary radiotherapy with Cf-252 for uterine cervical carcinomas]. Fukuda K Gan No Rinsho; 1984 Feb; 30(2):145-51. PubMed ID: 6608595 [TBL] [Abstract][Full Text] [Related]
7. Californium-252: isotope for modern radiotherapy of cervix, uterine and vaginal carcinomas. Maruyama Y; Beach JL; van Nagell JR Strahlentherapie; 1984 Jun; 160(6):373-81. PubMed ID: 6464041 [TBL] [Abstract][Full Text] [Related]
8. Experience with californium 252 in clinical radiotherapy. Castro JR; Oliver GD; Withers HR; Almond PR Am J Roentgenol Radium Ther Nucl Med; 1973 Jan; 117(1):182-94. PubMed ID: 4685531 [No Abstract] [Full Text] [Related]
9. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study. Tacev T; Ptácková B; Strnad V Strahlenther Onkol; 2003 Jun; 179(6):377-84. PubMed ID: 12789463 [TBL] [Abstract][Full Text] [Related]
11. [252Cf in combined radiation therapy of cancer of the uterine cervix]. Pozmogov AI; Abdullaev VD; Letov VN; Sul'kin AG; Skliar MN Med Radiol (Mosk); 1976 Dec; 21(12):53-6. PubMed ID: 1025419 [No Abstract] [Full Text] [Related]
12. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study. Tacev T; Vacek A; Ptácková B; Strnad V Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423 [TBL] [Abstract][Full Text] [Related]
13. [Immediate and early results with the contact irradiation of tumors using 252Cf sources]. Vtiurin BM; Galantseva GF; Medvedev VS; Abdulkadyrov SA Radiobiol Radiother (Berl); 1983; 24(2):157-63. PubMed ID: 6867298 [No Abstract] [Full Text] [Related]
14. Early changes in flow cytometric DNA profiles induced by californium-252 neutron brachytherapy in squamocellular carcinomas of the uterine cervix. Tacev T; Zaloudík J; Janáková L; Vagunda V Neoplasma; 1998; 45(2):96-101. PubMed ID: 9687890 [TBL] [Abstract][Full Text] [Related]
15. Experience with 252 Cf in radiotherapy. Oliver GD; Castro JR; Almond PR Br J Radiol; 1971 Nov; 44(527):903. PubMed ID: 5123611 [No Abstract] [Full Text] [Related]
16. Absorbed dose and linear energy transfer distributions form therapeutic sources of 252 Cf. Jones TD; Auxier JA Phys Med Biol; 1972 Mar; 17(2):206-17. PubMed ID: 5072545 [No Abstract] [Full Text] [Related]
17. [Comparison of the accuracy of methods of pre-irradiation preparation of patients with cancer of the cervix for intracavitary radiotherapy]. Merkle K; Spasokukotskaia ON; Poltorakin IA Med Radiol (Mosk); 1983 Jan; 28(1):32-7. PubMed ID: 6827930 [No Abstract] [Full Text] [Related]
18. Neutron and gamma dose distribution for tandem, tandem and ovoid and plaque for intracavitary 252Cf therapy of cervix carcinoma. Maruyama Y; Tai DL; Beach JL Radiat Med; 1983; 1(3):230-6. PubMed ID: 6390538 [TBL] [Abstract][Full Text] [Related]
19. [Recurrences of mouth and skin cancers after endocurietherapy with iridium 192]. Baillet F; Kanoui A; Julliard JC; Raynal M; Chassagne D; Pierquin B J Radiol Electrol Med Nucl; 1971 Nov; 52(11):755-7. PubMed ID: 5146869 [No Abstract] [Full Text] [Related]
20. Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase II trial. Maruyama Y; van Nagell JR; Yoneda J; Gallion HH; DePriest P; Feola JM; Wierzbicki J Am J Clin Oncol; 1993 Apr; 16(2):168-74. PubMed ID: 8452113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]